JP2023534460A5 - - Google Patents
Info
- Publication number
- JP2023534460A5 JP2023534460A5 JP2023502701A JP2023502701A JP2023534460A5 JP 2023534460 A5 JP2023534460 A5 JP 2023534460A5 JP 2023502701 A JP2023502701 A JP 2023502701A JP 2023502701 A JP2023502701 A JP 2023502701A JP 2023534460 A5 JP2023534460 A5 JP 2023534460A5
- Authority
- JP
- Japan
- Prior art keywords
- mod
- cell
- cognitive
- control
- binding affinity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063051472P | 2020-07-14 | 2020-07-14 | |
| US63/051,472 | 2020-07-14 | ||
| US202063110929P | 2020-11-06 | 2020-11-06 | |
| US63/110,929 | 2020-11-06 | ||
| US202063120677P | 2020-12-02 | 2020-12-02 | |
| US63/120,677 | 2020-12-02 | ||
| PCT/US2021/041675 WO2022015880A2 (en) | 2020-07-14 | 2021-07-14 | T-cell modulatory polypeptides with conjugation sites and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534460A JP2023534460A (ja) | 2023-08-09 |
| JP2023534460A5 true JP2023534460A5 (enExample) | 2024-07-26 |
Family
ID=79556024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502701A Pending JP2023534460A (ja) | 2020-07-14 | 2021-07-14 | コンジュゲーション部位を有するｔ細胞調節性ポリペプチド及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230279076A1 (enExample) |
| EP (1) | EP4182465A4 (enExample) |
| JP (1) | JP2023534460A (enExample) |
| KR (1) | KR20230052881A (enExample) |
| CN (1) | CN116437952A (enExample) |
| AU (1) | AU2021309842A1 (enExample) |
| CA (1) | CA3174097A1 (enExample) |
| IL (1) | IL299834A (enExample) |
| TW (1) | TW202216750A (enExample) |
| WO (1) | WO2022015880A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11505591B2 (en) * | 2016-05-18 | 2022-11-22 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| KR102760578B1 (ko) | 2016-12-22 | 2025-02-03 | 큐 바이오파마, 인크. | T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| WO2023201234A2 (en) * | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| JP2025515575A (ja) * | 2022-04-14 | 2025-05-20 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞エンゲージングポリペプチドおよびその使用方法 |
| WO2024206207A1 (en) * | 2023-03-24 | 2024-10-03 | Neximmune, Inc. | Injectable artificial antigen presenting cells for immune therapy |
| EP4484441A1 (en) * | 2023-06-26 | 2025-01-01 | Eberhard-Karls-Universität Tübingen | Mhc-class i derived polypeptide |
| CN118027176B (zh) * | 2024-03-27 | 2024-12-24 | 郑春杨 | 人β2-微球蛋白突变体 |
| WO2025207816A1 (en) * | 2024-03-27 | 2025-10-02 | Cue Biopharma, Inc. | Treatment of b-cell mediated immune disorders by t-cell mediated depletion of b cells, plasmablasts and plasma cells |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014096015A1 (en) * | 2012-12-21 | 2014-06-26 | F. Hoffmann-La Roche Ag | Disulfide-linked multivalent mhc class i comprising multi-function proteins |
| CA3014458A1 (en) * | 2016-03-02 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) * | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| EA202090471A1 (ru) * | 2017-09-07 | 2020-06-10 | Кью Биофарма, Инк. | Модулирующие т-клетки мультимерные полипептиды и способы их применения |
| CN111712254A (zh) * | 2017-12-23 | 2020-09-25 | 鲁比厄斯治疗法股份有限公司 | 人工抗原呈递细胞和使用方法 |
| WO2020132366A2 (en) * | 2018-12-19 | 2020-06-25 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof |
| TWI856047B (zh) * | 2018-12-19 | 2024-09-21 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| IL293978A (en) * | 2019-12-20 | 2022-08-01 | Regeneron Pharma | New il2 agonists and methods of using them |
-
2021
- 2021-07-14 KR KR1020237004718A patent/KR20230052881A/ko active Pending
- 2021-07-14 WO PCT/US2021/041675 patent/WO2022015880A2/en not_active Ceased
- 2021-07-14 AU AU2021309842A patent/AU2021309842A1/en not_active Abandoned
- 2021-07-14 JP JP2023502701A patent/JP2023534460A/ja active Pending
- 2021-07-14 US US18/005,813 patent/US20230279076A1/en active Pending
- 2021-07-14 CA CA3174097A patent/CA3174097A1/en active Pending
- 2021-07-14 TW TW110125957A patent/TW202216750A/zh unknown
- 2021-07-14 IL IL299834A patent/IL299834A/en unknown
- 2021-07-14 CN CN202180061013.8A patent/CN116437952A/zh active Pending
- 2021-07-14 EP EP21842034.7A patent/EP4182465A4/en active Pending